Fig. 4From: A novel necroptosis signature for predicting survival in lung adenocarcinomaKaplan-Meier results of the NRG signature using stratification analyses of KRAS mutation status, TP53 mutation status, and EGFR mutation status, including (A) KRAS mutation, (B) KRAS wild − type (negative), (C) EGFR mutation, (D) EGFR wild − type (negative), (E)TP53 mutation, (F) TP53 wild − type (negative)Back to article page